IGF1R and cancer: Also, drugs that induce a G2–M arrest and target the SAC, such as PARP inhibitors (PARPi; ref. 57), cetuximab (75), IGF1R, and LCK inhibitors (46, 55, 56), seemed to particularly predict efficiency against cancer cells with a high ENI10 score.